Challenge models to assess new therapies in chronic obstructive pulmonary disease.
about
Human rhinovirus 16 causes Golgi apparatus fragmentation without blocking protein secretion.Expression of calgranulin A/B heterodimer after acute inhalation of endotoxin: proteomic approach and validation.Anti-TNF inhibits the airways neutrophilic inflammation induced by inhaled endotoxin in human.An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
P2860
Challenge models to assess new therapies in chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenge models to assess new therapies in chronic obstructive pulmonary disease.
@en
type
label
Challenge models to assess new therapies in chronic obstructive pulmonary disease.
@en
prefLabel
Challenge models to assess new therapies in chronic obstructive pulmonary disease.
@en
P2860
P921
P356
P1476
Challenge models to assess new therapies in chronic obstructive pulmonary disease.
@en
P2093
Nestor A Molfino
René van der Merwe
P2860
P304
P356
10.2147/COPD.S30664
P407
P577
2012-09-13T00:00:00Z